It seems that IL-6 might contribute to CTCL progression by over-activated STAT3 signaling but certainly IL-6 plays a significant role in inflammation process in CTCL [17]. Here, STAT3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.